Search research articles
Contact Us
Filters
Showing results (151-160 of 573) with videos related to
Page
of 58
Sort By:
Blood
|
May 1, 1993
Hypercoagulability during induction therapy of acute lymphoblastic leukemia is of scarce clinical relevance. Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto
V de Stefano, L Gugliotta, M G Mazzucconi, et al.
Haematologica
|
April 28, 2001
Molecular evaluation of the NUP98/RAP1GDS1 gene frequency in adults with T-acute lymphoblastic leukemia
G Cimino, T Sprovieri, M C Rapanotti, et al.
Journal of Biological Regulators and Homeostatic Agents
|
April 1, 1987
Recombinant interferon alpha-2 modulates hairy cell phenotype "in vitro"
A Fattorossi, A Dolei, J G Pizzolo, et al.
Tumori
|
June 30, 1986
Unusual dermatologic toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemia
E Montefusco, G Alimena, R Gastaldi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Pharmacological purging of syngeneic bone marrow ex vivo: effect of treatment with doxorubicin and lonidamine on normal and leukaemic cells of DBA/2 mice
A Sandrelli, P De Fabritiis, A Capua, et al.
Haematologica
|
July 1, 1990
Hodgkin's disease (HD) and human immunodeficiency virus (HIV) seropositivity. Report of six cases
A P Anselmo, A Vitak, F Pizzo, et al.
Leukemia
|
February 1, 1989
Phase II trial of intermediate dose ARA-C (IDAC) with sequential mitoxantrone (MITOX) in acute myelogenous leukemia
S Amadori, G Meloni, M C Petti, et al.
European Journal of Haematology
|
May 1, 1989
Acute myelogenous leukemia in first relapse treated with two consecutive autologous bone marrow transplantations: a pilot study
G Meloni, P De Fabritis, A Pulsoni, et al.
European Journal of Haematology
|
March 1, 1989
Intermediate-dose (25 mg/m2) intravenous melphalan for patients with multiple myeloma in relapse or refractory to standard treatment
M T Petrucci, G Avvisati, M Tribalto, et al.
Recenti Progressi in Medicina
|
December 1, 1979
[The role of blood platelets in consumption coagulopathy]
G Mariani, M G Mazzucconi, G Avvisati, et al.
Page
of 58
Search research articles
Search
Showing results (151-160 of 573) with videos related to
Sort By:
Page
of 58
Blood
|
May 1, 1993
Hypercoagulability during induction therapy of acute lymphoblastic leukemia is of scarce clinical relevance. Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto
V de Stefano, L Gugliotta, M G Mazzucconi, et al.
Haematologica
|
April 28, 2001
Molecular evaluation of the NUP98/RAP1GDS1 gene frequency in adults with T-acute lymphoblastic leukemia
G Cimino, T Sprovieri, M C Rapanotti, et al.
Journal of Biological Regulators and Homeostatic Agents
|
April 1, 1987
Recombinant interferon alpha-2 modulates hairy cell phenotype "in vitro"
A Fattorossi, A Dolei, J G Pizzolo, et al.
Tumori
|
June 30, 1986
Unusual dermatologic toxicity of long-term therapy with hydroxyurea in chronic myelogenous leukemia
E Montefusco, G Alimena, R Gastaldi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Pharmacological purging of syngeneic bone marrow ex vivo: effect of treatment with doxorubicin and lonidamine on normal and leukaemic cells of DBA/2 mice
A Sandrelli, P De Fabritiis, A Capua, et al.
Haematologica
|
July 1, 1990
Hodgkin's disease (HD) and human immunodeficiency virus (HIV) seropositivity. Report of six cases
A P Anselmo, A Vitak, F Pizzo, et al.
Leukemia
|
February 1, 1989
Phase II trial of intermediate dose ARA-C (IDAC) with sequential mitoxantrone (MITOX) in acute myelogenous leukemia
S Amadori, G Meloni, M C Petti, et al.
European Journal of Haematology
|
May 1, 1989
Acute myelogenous leukemia in first relapse treated with two consecutive autologous bone marrow transplantations: a pilot study
G Meloni, P De Fabritis, A Pulsoni, et al.
European Journal of Haematology
|
March 1, 1989
Intermediate-dose (25 mg/m2) intravenous melphalan for patients with multiple myeloma in relapse or refractory to standard treatment
M T Petrucci, G Avvisati, M Tribalto, et al.
Recenti Progressi in Medicina
|
December 1, 1979
[The role of blood platelets in consumption coagulopathy]
G Mariani, M G Mazzucconi, G Avvisati, et al.
Page
of 58